Does riociguat improve exercise capacity in patients with pulmonary arterial hypertension?
Riociguat provides significant improvement in exercise capacity for patients with pulmonary arterial hypertension.
Riociguat significantly improved exercise capacity and secondary efficacy end points in patients with pulmonary arterial hypertension. (Funded by Bayer HealthCare; PATENT-1 and PATENT-2 ClinicalTrials.gov numbers, NCT00810693 and NCT00863681, respectively.).
Building similarity graph...
Analyzing shared references across papers
Loading...
New England Journal of Medicine
University of California, San Diego
Inserm
Imperial College London
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Ghofrani et al. (Wed,) studied this question.